ABT

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and…

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…

Abbott Laboratories  (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations,…

Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday,…

Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…

Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell…

Abbott Laboratories  (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing…

Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a…

When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one…

Abbott Laboratories  (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing…